{"id":"CHEMBL10372","canonicalSmiles":"O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2ccccc12","inchiKey":"BCSVCWVQNOXFGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOPOLRESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alond","CP-73,850","CP-73850","Zopolrestat"],"crossReferences":{"drugbank":["DB08772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076930","canonicalSmiles":"CO[C@@H]1[C@H](OP(=O)(OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O","inchiKey":"CJCYTUJOSMYXLE-JDLSZIHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INARIGIVIR SOPROXIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inarigivir soproxil","SB 9200","SB-44","SB-9200","Sb 9200"],"crossReferences":{"drugbank":["DB15063"]},"childChemblIds":["CHEMBL3526317"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1086997","canonicalSmiles":"CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO","inchiKey":"UQRORFVVSGFNRO-XFWSIPNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCERASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-434964","Lucerastat","N-N-Butyl Deoxygalactonojirimycin"],"crossReferences":{"drugbank":["DB14872"]},"linkedTargets":{"rows":["ENSG00000148154"],"count":1},"linkedDiseases":{"rows":["Orphanet_324"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL109005","canonicalSmiles":"CC(=O)Nc1c(N)cc(C(=O)O)cc1O","inchiKey":"CALDTVBHJMBRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109005","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11608","canonicalSmiles":"NCCc1ccc(O)cc1","inchiKey":"DZGWFCGJZKJUFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYRAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-p-hydroxyphenylethylamine","FEMA NO. 4215","NSC-249188","Ractopamine hydrochloride suspension impurity, tyramine-","Systogene","Tocosine","Tyramine","Tyrosamine","Uteramine"],"crossReferences":{"PubChem":["104171251","11111872","144203833","170466815","858070","90341354"],"Wikipedia":["Tyramine"],"drugbank":["DB08841"],"chEBI":["15760"]},"childChemblIds":["CHEMBL1255790"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL117822","canonicalSmiles":"C=C","inchiKey":"VGGSQFUCUMXWEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylene"],"crossReferences":{"Wikipedia":["Ethylene"],"chEBI":["18153"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL119296","canonicalSmiles":"NCCCCCN","inchiKey":"VHRGRCVQAFMJIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Pentane-1,5-Diamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentane-1,5-Diamine"],"crossReferences":{"PubChem":["29218043"],"Wikipedia":["Cadaverine"],"drugbank":["DB03854"],"chEBI":["18127"]},"childChemblIds":["CHEMBL3351096"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200341","canonicalSmiles":"CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21.Cl","inchiKey":"NXNSCUZKMVYAJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDECAINIDE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201242","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decabid"],"synonyms":["Indecainide hcl","Indecainide hydrochloride","LY 135837","LY-135837","LY-135857","Ricainide"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200356","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O","inchiKey":"HGBLNBBNRORJKI-WCABBAIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLACILLIN","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calthor","Cyclacillin","Cyclapen","Cyclapen-w","Vasticillin"],"synonyms":["Ciclacillin","Cyclacillin","NSC-88789","Vastcillin","WY-4508"],"crossReferences":{"PubChem":["11112536","144204085","396250"],"Wikipedia":["Ciclacillin"],"drugbank":["DB01000"],"chEBI":["31444"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1200473","canonicalSmiles":"CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1.Cl","inchiKey":"RHKZVMUBMXGOLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTOLATE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201338","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ak-pentolate","Akpentolate","Alnide","Cyclogyl","Cyclopentolate hydrochloride","Mydrilate","Pentolair"],"synonyms":["Cyclopentolate hcl","Cyclopentolate hydrochloride","Cylate","Cyplegin","NSC-756706"],"crossReferences":{"DailyMed":["cyclopentolate%20hydrochloride"],"PubChem":["170464720","26747954","56320713","855558"],"Wikipedia":["Cyclopentolate"],"chEBI":["4025"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0011499"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for mydriasis."}
{"id":"CHEMBL1200903","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)[N-]C(=O)NC1=O.[Na+]","inchiKey":"AXXJTNXVUHVOJW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SECOBARBITAL SODIUM","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL447","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Secobarbital sodium","Seconal sodium","Seconesin","Tuinal"],"synonyms":["(rs)-secobarbital sodium","Barbosec","Evronal sodium","Immenoctal","NSC-10818","Pramil","Quinalbarbitone sodium","Sebar","Secobarbital sodium","Synate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950. It was withdrawn in France and  Norway initially in 1980 due to Misuse."}
{"id":"CHEMBL1201482","drugType":"Enzyme","blackBoxWarning":false,"name":"PROTEASE (PANCRELIPASE)","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Protease","Protease (pancrelipase)"],"crossReferences":{"DailyMed":["protease%20(pancrelipase)"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 investigational indications."}
{"id":"CHEMBL1201626","drugType":"Unknown","blackBoxWarning":false,"name":"CHYMOPAPAIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chymodiactin","Discase"],"synonyms":["BAX 1526","BAX-1526","Chymopapain","NSC-107079"],"crossReferences":{"DrugCentral":["5131"],"Wikipedia":["Chymopapain"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201758","canonicalSmiles":"O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1","inchiKey":"YWGDOWXRIALTES-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPOTASTINE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bepreve"],"synonyms":["Bepotastine","Betotastine"],"crossReferences":{"DailyMed":["bepotastine%20besilate"],"Wikipedia":["Bepotastine"],"chEBI":["71204"]},"childChemblIds":["CHEMBL1201759"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0002406","MONDO_0005271","EFO_0007141","EFO_1001417","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for pruritus and allergic conjunctivitis and has 4 investigational indications."}
{"id":"CHEMBL1201777","canonicalSmiles":"CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl","inchiKey":"ZELFLGGRLLOERW-YECZQDJWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAPENTADOL HYDROCHLORIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201776","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nucynta","Nucynta er","Palexia"],"synonyms":["BN-200 HYDROCHLORIDE","CG-5503 HYDROCHLORIDE","CG5503 HYDROCHLORIDE","Tapentadol hcl","Tapentadol hydrochloride"],"crossReferences":{"DailyMed":["tapentadol%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","HP_0012532","EFO_1000786","EFO_0004616","HP_0003419","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1207907","canonicalSmiles":"CC(C)(CS(=O)(=O)O)N(Cl)Cl","inchiKey":"QYNRGGHZWCUZLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AURICLOSENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Auriclosene","NVC-422","Nvc-422"],"crossReferences":{"drugbank":["DB12197"]},"childChemblIds":["CHEMBL453144","CHEMBL4297434"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1229967","canonicalSmiles":"CC1(C)N[C@H](C(=O)O)CS1","inchiKey":"OCQICQZUUHJWGZ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229967","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01635"],"chEBI":["39764"]},"childChemblIds":["CHEMBL3245367"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230612","canonicalSmiles":"CCN(C(=O)c1cc(C)cc(OC[C@H](C)Nc2ccncc2)c1)C(C)C","inchiKey":"JMPSZYHYDMQFEO-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230612","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07279"]},"childChemblIds":["CHEMBL3182786"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231518","canonicalSmiles":"COc1cc(O)c(C(=O)/C=C/c2ccc(O)cc2)cc1CC=C(C)C","inchiKey":"ZUGCRBMNFSAUOC-YRNVUSSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231518","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07500"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232164","canonicalSmiles":"O=C(O)CCCCCCCCC(=O)O","inchiKey":"CXMXRPHRNRROMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEBACIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208976","82387"],"drugbank":["DB07645"],"chEBI":["41865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232236","canonicalSmiles":"CC(C)OP(C)(=O)OC(C)C","inchiKey":"WOAFDHWYKSOANX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPHOSPHONIC ACID DIISOPROPYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208910","144210792"],"drugbank":["DB02127"],"chEBI":["77325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232411","canonicalSmiles":"COCCOC","inchiKey":"XTHFKEDIFFGKHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207618"],"drugbank":["DB01749"],"chEBI":["42263"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232562","canonicalSmiles":"CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DNVPQKQSNYMLRS-APGDWVJJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOSTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ergosterol D"],"crossReferences":{"Wikipedia":["Ergosterol"],"drugbank":["DB04038"],"chEBI":["16933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232770","canonicalSmiles":"O=C1C(O)=CC(=O)c2c(O)cc(O)cc21","inchiKey":"RROPNRTUMVVUED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVIOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02521"],"chEBI":["42646"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232777","canonicalSmiles":"O=c1[nH]cnc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)n[nH]c12","inchiKey":"MTCJZZBQNCXKAP-KSYZLYKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMYCIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04198"],"chEBI":["42654"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232971","canonicalSmiles":"O=C(/C=C/c1ccc(Cl)cc1)NO","inchiKey":"YPYUWBDOEMPXSK-ZZXKWVIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232971","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07819"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233129","canonicalSmiles":"CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O","inchiKey":"QTQDDTSVRVWHMO-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-METHYLGLUTATHIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235151","canonicalSmiles":"NCc1[nH]cc(CCC(=O)O)c1CC(=O)O","inchiKey":"QSHWIQZFGQKFMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02272"],"chEBI":["17381"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254771","canonicalSmiles":"COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1","inchiKey":"AMTQCENHQIDBHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFOTIBANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FOV-2304","Fov2304","LF22-0542","Lf 22-0542","Lf-22-0542","Safotibant","Safotibant phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1258517","canonicalSmiles":"O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1","inchiKey":"WXUUCRLKXQMWRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PKI-179","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PKI-179","Pki-179"],"linkedTargets":{"rows":["ENSG00000121879","ENSG00000198793"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1404","canonicalSmiles":"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1","inchiKey":"XKLMZUWKNUAPSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANOLAZINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ranexa","Ranolazine"],"synonyms":["CVT-303","NSC-759100","RS-43285-003","Ran d","Ranolazine"],"crossReferences":{"DailyMed":["ranolazine"],"PubChem":["104171232","170465435","174006299","26749060","26749061","50107515","56463697","90340842"],"Wikipedia":["Ranolazine"],"drugbank":["DB00243"],"chEBI":["87690"]},"childChemblIds":["CHEMBL1526084","CHEMBL537649"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000007314"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003086","MONDO_0005149","EFO_0001361","EFO_0009276","EFO_0000275","EFO_0000555","EFO_0001645","EFO_0000319","EFO_0000538","HP_0001657","EFO_0000384","Orphanet_684","EFO_0003913","EFO_0000195","EFO_1001375","MONDO_0004976","MONDO_0011377","MONDO_0005148","EFO_0000407","EFO_0005672","EFO_0004264","EFO_1000899","HP_0001653"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for angina pectoris and cardiovascular disease and has 15 investigational indications."}
{"id":"CHEMBL1447815","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIUM CHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["indium%20in-111%20chloride"],"PubChem":["124889857","124889858","144204550","144214028","17388973"]},"childChemblIds":["CHEMBL3187636","CHEMBL1201078"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992."}
{"id":"CHEMBL1486","canonicalSmiles":"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O","inchiKey":"VCMJCVGFSROFHV-WZGZYPNHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR DISOPROXIL FUMARATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1538","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tenofovir disoproxil fumarate","Viread"],"synonyms":["GS-1278","GS-4331-05","GS-4331-05-","GSK-548470","GSK548470","PMPA","PMPA PRODRUG","PMPA Prodrug","PMPA-PRODRUG","Tenofovir","Tenofovir df","Tenofovir disoproxil fumarate","Tenofoviri disoproxili fumaras","Virea","Viread"],"crossReferences":{"DailyMed":["tenofovir%20disoproxil%20fumarate"],"PubChem":["144207176"],"chEBI":["63718"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 6 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1568","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"HBUBKKRHXORPQB-FJFJXFQQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDARABINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Fluoro-Ara-A","Fludarabine"],"crossReferences":{"PubChem":["144206348","144206969","170464764","855645"],"Wikipedia":["Fludarabine"],"drugbank":["DB01073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1607273","canonicalSmiles":"Cl.Cl.O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"PGLIUCLTXOYQMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETIRIZINE HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1000","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allacan","Allertek","Becoallergy","Cetec","Cetirizine hydrochloride","Cetirizine hydrochloride allergy","Cetirizine hydrochloride hives","Cetirizine hydrochloride hives relief","Cetirocol","Children's cetirizine hydrochloride allergy","Children's cetirizine hydrochloride hives relief","Children's zyrtec allergy","Children's zyrtec hives relief","Piriteze","Pollenshield","Quzyttir","Zerviate","Ziralton","Zirtek","Zynor","Zyrtec","Zyrtec allergy","Zyrtec hives relief"],"synonyms":["Cetirizine","Cetirizine dihydrochloride","Cetirizine hcl","Cetirizine hydrochloride","Cetrine","NSC-759102","P 071","P-071","Zyrtec"],"crossReferences":{"DailyMed":["cetirizine%20hydrochloride"],"PubChem":["144204255","144212578","170465442","26749066"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005531","MONDO_0005301","MONDO_0005271","EFO_0003830","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1628385","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CCN(CC)CCOC(=O)c1ccc(N)cc1","inchiKey":"WHRVRSCEWKLAHX-LQDWTQKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCAINE BENZYLPENICILLIN","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicillin","Cilicaine syringe","Depocillin"],"synonyms":["E707","Procaine benzylpenicillin"],"crossReferences":{"DailyMed":["penicillin%20g%20procaine"],"DrugCentral":["4459"],"Wikipedia":["Procaine_benzylpenicillin"],"drugbank":["DB09320"],"chEBI":["52154"]},"childChemblIds":["CHEMBL1200936"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for bacterial disease and infection and has 3 investigational indications."}
{"id":"CHEMBL16293","canonicalSmiles":"c1ccc2ccccc2c1","inchiKey":"UFWIBTONFRDIAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHTHALENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albocarbon","Dezodorator","NSC-37565","Naftalen","Naphthalene","Naphthalinum","Tar camphor","White tar"],"crossReferences":{"PubChem":["144204574","144209202","144210328","17389811","225144198","26752807","49816690"],"Wikipedia":["Naphthalene"],"chEBI":["16482"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL164138","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)C1CCCC1)C(=O)c1nc2ccccc2s1","inchiKey":"NQABUEUFRXDDFI-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL164138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03251"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697837","canonicalSmiles":"CN(CC(=O)N1CCOCC1)Cc1c(Cl)cccc1NC(=O)c1ccccc1","inchiKey":"KSNNEUZOAFRTDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOMINOBEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fominoben","Fominoben hydrochloride","PB 89 [AS HYDROCHLORIDE]"],"crossReferences":{"drugbank":["DB08968"]},"childChemblIds":["CHEMBL2356122"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1789844","drugType":"Antibody","blackBoxWarning":false,"name":"IPILIMUMAB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yervoy"],"synonyms":["BMS-734016","BMS734016","Ipilimumab","MDX-010","MDX-010 MDX-CTLA4","MDX-101","MDX-CTLA-4","MDX010"],"crossReferences":{"DailyMed":["ipilimumab"],"DrugCentral":["4958"]},"linkedTargets":{"rows":["ENSG00000163599"],"count":1},"linkedDiseases":{"rows":["EFO_0003891","EFO_1000403","EFO_0000365","EFO_0001075","EFO_0000558","EFO_0000756","EFO_0000681","EFO_0000571","MONDO_0045056","EFO_1000657","EFO_0005952","EFO_0000228","EFO_1000984","EFO_1001951","MONDO_0017582","EFO_0000588","EFO_0000339","EFO_0000096","EFO_0009709","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0008528","MONDO_0020634","Orphanet_2495","EFO_0000198","EFO_0002618","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","MONDO_0004669","EFO_1001512","EFO_1001968","MONDO_0008315","EFO_0001663","EFO_1000344","MONDO_0002691","EFO_0001061","MONDO_0002547","MONDO_0000544","EFO_0004284","EFO_0008524","EFO_0000574","EFO_1000613","EFO_0001378","EFO_0006544","EFO_0000563","EFO_0001376","MONDO_0009348","EFO_1001972","MONDO_0100342","MONDO_0015686","MONDO_0045069","EFO_1001465","MONDO_0007254","EFO_0000708","EFO_0004252","MONDO_0002087","MONDO_0024879","MONDO_0021063","EFO_0000305","EFO_0003085","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","Orphanet_377","EFO_0007466","EFO_1001974","EFO_0000770","MONDO_0002898","EFO_0000673","EFO_0000196","EFO_0000183","EFO_0004193","MONDO_0020743","EFO_0000707","EFO_0002617","EFO_0000616","EFO_0006859","EFO_1000616","EFO_0002916","EFO_0000503","EFO_1000314","Orphanet_44890","EFO_0000403","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0004243","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0003863","EFO_1001471","EFO_0000304","MONDO_0002120","EFO_0000095","EFO_0002517","EFO_0000764","EFO_0000702","EFO_0004142","MONDO_0002367","MONDO_0003219","EFO_1000081","MONDO_0024880","EFO_1001950","EFO_0000519","EFO_0000181","EFO_0000691","EFO_1001927"],"count":113},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 5 approved and 86 investigational indications."}
{"id":"CHEMBL186141","canonicalSmiles":"C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)CO)[C@@H]1C/C=C1/C(=O)OC[C@H]1O","inchiKey":"BOJKULTULYSRAS-OTESTREVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROGRAPHOLIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andrographolide","HMPL-004","HMPL004","NSC-383468"],"crossReferences":{"PubChem":["144205061"],"drugbank":["DB05767"],"chEBI":["65408"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL186179","canonicalSmiles":"COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1","inchiKey":"IRLWJILLXJGJTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MURAGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-298585","BMS-298585-01","MK-0478","MK0478","Muraglitazar"],"crossReferences":{"PubChem":["170466259"],"drugbank":["DB06510"]},"childChemblIds":["CHEMBL3527055","CHEMBL557580"],"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0000400","MONDO_0005148","Orphanet_309005"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1908371","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"MVPQUSQUURLQKF-ABIFMKGDSA-E","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"IDRAPARINUX SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1908845","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idraparinux nonasodium salt","Idraparinux sodium","ORG-34006","SANORG-34006","SANORG34006"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003827","EFO_0003907"],"count":3},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1909285","canonicalSmiles":"Cc1nc([N+](=O)[O-])cn1-c1ccc([N+](=O)[O-])cc1","inchiKey":"NMTBSNPBIGRZBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITREFAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hematological toxicity"," Hepatotoxicity"],"year":1984},"tradeNames":[],"synonyms":["EMD 15 700","EMD-15-700","Nitrefazole"],"crossReferences":{"PubChem":["144206859"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1984 due to Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL191","canonicalSmiles":"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"PSIFNNKUMBGKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOSARTAN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Allisartan","Angizaar","Dup-89","HGP-1405","HGP1405","Losartan","Losartic","Lozap","NSC-758699"],"crossReferences":{"DailyMed":["losartan%20potassium"],"PubChem":["144204988","170465135","26748956"],"Wikipedia":["Losartan"],"drugbank":["DB00678"],"chEBI":["6541"]},"childChemblIds":["CHEMBL367465","CHEMBL995"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000637","EFO_0003095","EFO_0000275","EFO_0000401","EFO_0007148","EFO_1000653","EFO_0004253","EFO_0003884","EFO_0004616","EFO_0002618","MONDO_0005149","EFO_0000180","EFO_0004236","EFO_0004194","Orphanet_558","EFO_0000384","EFO_0004232","EFO_0000546","GO_0007568","MP_0001845","MONDO_0100096","EFO_0006818","EFO_0006505","EFO_0000668","EFO_0003086","Orphanet_232","EFO_0000464","EFO_0000768","EFO_1001249","MONDO_0007254","Orphanet_586","EFO_0000373","MONDO_0002462","EFO_0000538","EFO_1000637","Orphanet_416","EFO_1000044","EFO_0003144","EFO_0000712","EFO_0009321","EFO_0002617","EFO_0000694","HP_0002140","HP_0000093","EFO_0001645","EFO_0001358","EFO_0000319","EFO_0000537","EFO_0003896","MONDO_0001134","EFO_0000764","EFO_0002517","MONDO_0005147","MONDO_0005148","EFO_0000519","EFO_0004265"],"count":57},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 6 approved and 41 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1910856","canonicalSmiles":"CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC(Oc2cccc(O)c2)C1","inchiKey":"WGOJWDWKHJHXSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03635659","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-3635659","PF03635659","Pf-03635659","Pf03635659"],"crossReferences":{"drugbank":["DB12408"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL191632","canonicalSmiles":"Nc1cncc(Cl)n1","inchiKey":"JTPXVCKCLBROOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02297"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197865","canonicalSmiles":"O=C1O/C(=C\\c2cccc3ccccc23)C(O)=C1c1ccc(Cl)cc1","inchiKey":"PLGHLEBIWUQEPR-PDGQHHTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL197865","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07296"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204785","canonicalSmiles":"COc1ccc(NCCNC(=O)[C@H](CC2CCCCC2)Nc2nc3ccccc3o2)cc1","inchiKey":"VFNWTXUFNNOQHD-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07839"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2048484","canonicalSmiles":"Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1","inchiKey":"XTNGUQKDFGDXSJ-ZXGKGEBGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CANAGLIFLOZIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Canagliflozin","JNJ-24831754-ZAE","JNJ-28431754","JNJ-28431754-AAA","TA-7284"],"crossReferences":{"DailyMed":["canagliflozin"],"drugbank":["DB08907"],"chEBI":["73274"]},"childChemblIds":["CHEMBL4594217","CHEMBL2103841"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0003144","MONDO_0005147","EFO_0000401","MONDO_0007254","EFO_0004194","MONDO_0005148","EFO_0000400","EFO_0001073","EFO_0000660"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2059073","canonicalSmiles":"COc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O","inchiKey":"CXVGEDCSTKKODG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULISOBENZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sungard"],"synonyms":["Benzophenone-4","Escalol 577","Ms 40","NSC-60584","NSC-760350","Seesorb 101s","Spectra-sorb uv 284","Sulfisobenzone","Sulisobenzone","Syntase 230","Uvasorb s 5","Uvinul d 5030","Uvinul ms 40","Uvinul ms-40","Viosorb 111"],"crossReferences":{"PubChem":["144205192","144209530","144213779","170465489"],"drugbank":["DB11185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103856","canonicalSmiles":"CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2","inchiKey":"QWKAUGRRIXBIPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATOPAXAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atopaxar","E-5555","E5555","ER-172594-00"],"crossReferences":{"drugbank":["DB12046"]},"childChemblIds":["CHEMBL2105699"],"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0005672"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103991","canonicalSmiles":"Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O","inchiKey":"IETKPTYAGKZLKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALAGLITAZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balaglitazone","DRF-2593","Drf-2593","NN-2344"],"crossReferences":{"drugbank":["DB12781"]},"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104273","canonicalSmiles":"CCN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2","inchiKey":"PHTMLLGDZBZXMW-AERCQKQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYBENZTROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panolid"],"synonyms":["Ethybenztropine","Etybenzatropine","UK-738"],"crossReferences":{"drugbank":["DB13468"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104612","canonicalSmiles":"O[C@H](CBr)[C@H](O)[C@H](O)[C@@H](O)CBr","inchiKey":"VFKZTMPDYBFSTM-GUCUJZIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOLACTOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibromdulcit","Dibromodulcitol","Elobromol","Mitolactol","NCI-C04795","NSC-104800"],"crossReferences":{"drugbank":["DB12916"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105044","canonicalSmiles":"CCOC(=O)CSCCC1NC(C(=O)O)CS1","inchiKey":"IKOCLISPVJZJEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETOSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Letosteine","Viscotiol"],"crossReferences":{"drugbank":["DB08939"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105611","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C[C@@H](O)C[C@@H]1O","inchiKey":"BJYLYJCXYAMOFT-RSFVBTMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACALCITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Curatoderm"],"synonyms":["1.alpha.,24-dihydroxyvitamin d3","Bonalfa","Tacalcitol"],"crossReferences":{"drugbank":["DB13689"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psoriasis vulgaris and psoriasis."}
{"id":"CHEMBL2105760","canonicalSmiles":"O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1","inchiKey":"ZKIAIYBUSXZPLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BREXPIPRAZOLE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rexulti"],"synonyms":["Brexpiprazole","OPC-34712"],"crossReferences":{"DailyMed":["brexpiprazole"],"drugbank":["DB09128"]},"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000102468"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002009","HP_0012076","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0008568","HP_0000713","EFO_0000289","MONDO_0002050","MONDO_0004975","EFO_0003761","MONDO_0007079","EFO_0005411","MONDO_0002025"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106873","canonicalSmiles":"O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2]","inchiKey":"GVALZJMUIHGIMD-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"DrugCentral":["4596"],"drugbank":["DB13862"]},"childChemblIds":["CHEMBL3989627"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107324","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(N)=O","inchiKey":"GBONBLHJMVUBSJ-FAUHKOHMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CORTICORELIN ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xerecept"],"synonyms":["Corticorelin acetate","Corticorelin acetate human","NEU 3002","NEU-3002 ACETATE"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108285","drugType":"Antibody","blackBoxWarning":false,"name":"CAPROMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Capromab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109508","drugType":"Antibody","blackBoxWarning":false,"name":"IMMURAIT-LL2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMMURAIT-LL2"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231616","canonicalSmiles":"NC(=S)N/N=C/c1ncccc1N","inchiKey":"XMYKNCNAZKMVQN-NYYWCZLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-AP","NSC-663249","OCX-0191","OCX-191","Ocx 191","PAN-811","Triapine"],"crossReferences":{"PubChem":["510133"],"Wikipedia":["3-Aminopyridine-2-carboxaldehyde_thiosemicarbazone"],"drugbank":["DB11940"]},"linkedTargets":{"rows":["ENSG00000167325","ENSG00000048392"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_1000044","EFO_0006861","EFO_1000238","MONDO_0024503","MONDO_0008903","EFO_0000478","MONDO_0005411","MONDO_0002367","EFO_0003060","MONDO_0008315"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2354444","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1","inchiKey":"KMSKQZKKOZQFFG-YXRRJAAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRARUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adriamycin, tetrahydropyranyl","Pirarubicin","Theprubicin","Thp-adm"],"crossReferences":{"PubChem":["144206155","170465822"],"drugbank":["DB11616"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2355333","canonicalSmiles":"CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl.O","inchiKey":"WFUAVXYXJOQWAZ-GVKRCPFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIMELDINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL37744","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom, Germany"],"classes":["Hepatotoxicity"],"year":1983},"tradeNames":[],"synonyms":["H 102/09 HYDROCHLORIDE","Zimeldine hcl","Zimeldine hydrochloride","Zimelidine hydrochloride"],"crossReferences":{"PubChem":["144204841","170466366"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom, Germany  in 1983 due to Hepatotoxicity."}
{"id":"CHEMBL2364608","canonicalSmiles":"Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O","inchiKey":"ZIAOVIPSKUPPQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORAVIRINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pifeltro"],"synonyms":["Doravirine","MK-1439","Mk-1439a"],"crossReferences":{"DailyMed":["doravirine"],"drugbank":["DB12301"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2364614","canonicalSmiles":"CN1Cc2cc(-c3ccc(N)nn3)ccc2[C@H](c2ccc3ccccc3c2)C1","inchiKey":"VCIBGDSRPUOBOG-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIAFENSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-820836","Liafensine"],"crossReferences":{"drugbank":["DB14878"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0009854"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2364628","canonicalSmiles":"O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO","inchiKey":"QGZYDVAGYRLSKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RICOLINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACY-1215","ACY-63","Ricolinostat"],"crossReferences":{"drugbank":["DB12376"]},"linkedTargets":{"rows":["ENSG00000094631"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0000095","EFO_0000574","EFO_0001378","EFO_0009387","EFO_0000305","EFO_1001959"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2403318","canonicalSmiles":"Cn1c(C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ncc(Br)cn5)n(C)c4c3)CCC2)nc2ccc(/C=C/C(=O)O)cc21","inchiKey":"BMAIGAHXAJEULY-UKTHLTGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELEOBUVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 207127","BI-207127","Deleobuvir"],"crossReferences":{"drugbank":["DB14850"]},"childChemblIds":["CHEMBL3137315"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL264373","canonicalSmiles":"Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1","inchiKey":"VQJHOPSWBGJHQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metoprine","NSC-19494","NSC-7364","TCMDC-123931"],"crossReferences":{"PubChem":["170466776","73253","92763928"],"drugbank":["DB04655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27193","canonicalSmiles":"C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1","inchiKey":"SGUAFYQXFOLMHL-ACJLOTCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILEVALOL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1990},"tradeNames":[],"synonyms":["(r,r)-labetalol","Dilevalol","Labetalol (r,r)-form"],"childChemblIds":["CHEMBL1204165"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It was withdrawn in United Kingdom  in 1990 due to Hepatotoxicity."}
{"id":"CHEMBL30044","canonicalSmiles":"N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1","inchiKey":"GMJFVGRUYJHMCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBROMPROPAMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibromopropamidine","Dibrompropamidine"],"crossReferences":{"PubChem":["124899409"],"Wikipedia":["Dibrompropamidine"],"drugbank":["DB13548"]},"childChemblIds":["CHEMBL2360824","CHEMBL3277938"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL301370","canonicalSmiles":"CC[C@H]1C(=O)Nc2ccc(F)cc2N1C(=O)OC(C)C","inchiKey":"KELNNWMENBUHNS-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPAVIRALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-420867","GW-420867X","HBY-1293","Opaviraline"],"crossReferences":{"drugbank":["DB07884"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303041","canonicalSmiles":"CC(C)c1sc(NC(=O)c2cc(NC(=O)c3cc(NC=O)cn3C)cn2C)nc1C(=O)NCCCN(C)C","inchiKey":"VDYCDKRATGWFDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303041","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137340","drugType":"Cell","blackBoxWarning":false,"name":"VIAGENPUMATUCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HS-110","Viagenpumatucel l","Viagenpumatucel-l"],"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL324168","canonicalSmiles":"N=C(N)c1ccc2cc(C(=O)Nc3ccc(CN)cc3)ccc2c1","inchiKey":"NLBDETRVUYOIHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324168","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02398"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3311228","canonicalSmiles":"O[C@@](Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cn1","inchiKey":"IDUYJRXRDSPPRC-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTESECONAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oteseconazole","VT-1161","Vt-1161"],"crossReferences":{"drugbank":["DB13055"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL339231","canonicalSmiles":"CO[C@H]1/C=C\\C=C(/C)C(=O)NC2=CC(=O)C(N)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@@H]1OC(N)=O)C2=O","inchiKey":"XYFFWTYOFPSZRM-TWNAANEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL339231","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL339611","canonicalSmiles":"CCSc1cc(OC)c(CC(C)N)cc1OC","inchiKey":"MCYCODJKXUJSAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL339611","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13940"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL343336","canonicalSmiles":"O=C(O)CCCn1c2c(c3ccccc3c1=O)C(=O)c1ccccc1-2","inchiKey":"AHIJTWCJGCWHMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL343336","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08159"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545094","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CCC23)C[C@@H](O)C[C@@H]1O","inchiKey":"XDBOQJCMEXOPMU-BAHYQGKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELOCALCITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bxl-628","Elocalcitol","Ro-26-9228"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545308","canonicalSmiles":"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1","inchiKey":"HUFOZJXAKZVRNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCILETINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVL-301","CNX-419","CO-1686","CS-1631","Rociletinib"],"crossReferences":{"drugbank":["DB11907"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL361506","canonicalSmiles":"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO","inchiKey":"YBVNFKZSMZGRAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMIDINE ISETHIONATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL55","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nebupent","Pentacarinat","Pentam","Pentamidine isethionate"],"synonyms":["MB 800","NSC-620107","NSC-757400","OCZ103-OS","Pentamidine diisethionate","Pentamidine diisetionate","Pentamidine isethionate","Pentamidine isetionate","Pentamidini isetionas","RP 2512"],"crossReferences":{"DailyMed":["pentamidine%20isethionate"],"PubChem":["144204293","144208920","144210632","170464786"],"chEBI":["7977"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL3707351","canonicalSmiles":"Cc1cc(O[C@@H](CCC(F)(F)F)c2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(C)(C)C)cc1","inchiKey":"FASLTMSUPQDLIB-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADOMEGLIVANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adomeglivant","Adomeglivant, (-)-","LY-2409021","LY2409021","Ly2409021"],"crossReferences":{"drugbank":["DB11704"]},"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0003884","MONDO_0005148"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707374","canonicalSmiles":"CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F.Cl","inchiKey":"GEDVJGOVRLHFQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMISELIMOD HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3707375","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amiselimod hydrochloride","MT-1303"],"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["EFO_0000729","EFO_0002690","EFO_0000676","EFO_0003929","EFO_0000384","EFO_0003767"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL370753","canonicalSmiles":"OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1","inchiKey":"YNZFUWZUGRBMHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPIPRAMOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-169867","Opipramol","Opipramol dura"],"crossReferences":{"PubChem":["26755651","29216400","90341209"],"Wikipedia":["Opipramol"],"drugbank":["DB12930"]},"childChemblIds":["CHEMBL1524185"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL373357","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O","inchiKey":"NVKAWKQGWWIWPM-MISPCMORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL373357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56314652"],"drugbank":["DB07447"],"chEBI":["2150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL374385","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+](=O)[O-])c1","inchiKey":"IOJUJUOXKXMJNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NCX-4016","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ncx-4016","Nitroaspirin"],"crossReferences":{"drugbank":["DB12445"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL376140","canonicalSmiles":"CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"FPZLLRFZJZRHSY-HJYUBDRYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TIGECYCLINE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tigecycline","Tygacil"],"synonyms":["Tigecycline","WAY-GAR-936"],"crossReferences":{"DailyMed":["tigecycline"],"PubChem":["144206463"],"Wikipedia":["Tigecycline"],"drugbank":["DB00560"],"chEBI":["149836"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for bacterial disease and infection and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL376359","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O","inchiKey":"ZSBOMTDTBDDKMP-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOGLIPTIN","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vipidia"],"synonyms":["Alogliptin"],"crossReferences":{"DailyMed":["alogliptin%20benzoate"],"Wikipedia":["Alogliptin"],"drugbank":["DB06203"],"chEBI":["72323"]},"childChemblIds":["CHEMBL227529","CHEMBL458537","CHEMBL459806"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL3833316","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)[O-])cc4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)[O-])[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O.[Na+].[Na+].[Na+].[Na+]","inchiKey":"QQDCIMVGFXSAJH-DJFGCAFRSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVIPANSEL SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3707446","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMI-1070","PF-06460031-02","PF-0646003102","Rivipansel sodium"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL39","canonicalSmiles":"NCCc1c[nH]c2ccc(O)cc12","inchiKey":"QZAYGJVTTNCVMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEROTONIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-HT","5-Hydroxytryptamine","Enteramine","Serotonin","Thrombotonin"],"crossReferences":{"PubChem":["11111288","11111289","124880365","26754231","26754232","26754233","26755328","50109811","50109812","90341122"],"Wikipedia":["Serotonin"],"drugbank":["DB08839"],"chEBI":["28790"]},"childChemblIds":["CHEMBL535832"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL391805","canonicalSmiles":"CN1CCc2nc(C(=O)N[C@@H]3CCCC[C@H]3NC(=O)c3cc4cc(Cl)ccc4[nH]3)sc2C1","inchiKey":"ARPFWVKYXJZULB-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391805","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07630"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989564","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"NZKFUBQRAWPZJP-BXKLGIMVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOBRAMYCIN SULFATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1747","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nebcin","Tobramycin sulfate","Tobramycin sulfate (pharmacy bulk)"],"synonyms":["Gernebcin","Nebicina","Obracin","Tobra","Tobradistin","Tobramycin sulfate","Tobramycin sulfate (2:5)","Tobramycin sulphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989823","canonicalSmiles":"NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2C[C@H](O)NC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O.O=S(=O)(O)O","inchiKey":"AQONYROJHRNYQQ-QMAPKBLTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VIOMYCIN SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3085436","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viocin sulfate"],"synonyms":["Florimycin sulfate","NSC-760360","Viomycin sulfate","Viomycin sulphate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3989850","canonicalSmiles":"CC1(C)C2CCC1(CS(=O)(=O)O)C(=O)C2=Cc1ccc(C=C2C(=O)C3(CS(=O)(=O)O)CCC2C3(C)C)cc1","inchiKey":"HEAHZSUCFKFERC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECAMSULE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mexoryl SX"],"synonyms":["Ecamsule","Ecamsule solution","Mexoryl","Mexoryl sx","NSC-760054"],"crossReferences":{"drugbank":["DB09534"]},"childChemblIds":["CHEMBL4303168"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006."}
{"id":"CHEMBL3989859","canonicalSmiles":"CC(=O)Oc1c(C)c(C)c2c(c1C)CCC(C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"ZAKOWWREFLAJOT-ADUHFSDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCOPHEROL ACETATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["E-tabs","E-vicotrat","Ephynal"],"synonyms":[".alpha.-tocopherol acetate","Aec tocopheryl acetate","Alpha tocopheryl acetate","Alpha-tocopherol acetate","Copherol 1250 c","Covitol 1100 c","Jeen vitamin e","Tinoderm e","Tocopherol acetate","Tocopherol acetate, unspecified","Tocopheryl","Tocopheryl acetate","Tocopheryl acetate,alpha","Univit-e acetate","Vitamin e acetate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and has 1 investigational indication."}
{"id":"CHEMBL3990029","drugType":"Antibody","blackBoxWarning":false,"name":"RISANKIZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skyrizi"],"synonyms":["655066-01","ABBV-066","BI655066","Bi-655066","Risankizumab","Risankizumab-rzaa"],"crossReferences":{"DailyMed":["risankizumab-rzaa"]},"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000710","MONDO_0100096","EFO_1001494","MONDO_0002406","EFO_0003898","EFO_0003778","EFO_0000676","MONDO_0004979","Orphanet_163927","EFO_0000540","EFO_0000384"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 8 investigational indications."}
{"id":"CHEMBL403664","canonicalSmiles":"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1","inchiKey":"OYVAGSVQBOHSSS-UAPAGMARSA-O","drugType":"Small molecule","blackBoxWarning":true,"name":"BLEOMYCIN","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bleo-kyowa"],"synonyms":["Blenamax","Bleocin","Bleomycin","Bleomycin hexal","Bleomycin hydrochloride","Bleomycins","NSC-125066"],"crossReferences":{"Wikipedia":["Bleomycin"],"chEBI":["3139"]},"childChemblIds":["CHEMBL3085504","CHEMBL4649901"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 6 approved and 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4112929","canonicalSmiles":"C[C@@H]1CCC[C@H](n2cnc(-c3cc(Cl)ccc3-n3cc(Cl)nn3)cc2=O)c2cc(ccn2)-c2c(cnn2C(F)F)NC1=O","inchiKey":"FSWFYCYPTDLKON-CMJOXMDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILVEXIAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 986177","BMS-986177","Bms-986177","JNJ-70033093","Jnj-70033093","Milvexian"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL42039","canonicalSmiles":"CCNC(=O)COc1ccc(Cl)cc1CNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C1CCCCC1","inchiKey":"BMHVHOJXEQTIEA-SIKLNZKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL42039","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06869"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425181","canonicalSmiles":"CCc1nn(-c2c(Cl)cc(Cl)cc2Cl)c2nc(Cc3ccc(O)c(O)c3)[nH]c(=O)c12","inchiKey":"OPRAIFVPXXVXDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425181","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07606"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297278","canonicalSmiles":"CC[C@H](O)[C@@H](C)[C@H]1O[C@@H]1C[C@@](C)(O)/C=C/C=C(\\C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(C3CCCCCC3)CC2)/C=C/[C@@H]1C","inchiKey":"MNOMBFWMICHMKG-MGYWSNOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E7107","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E7107"],"crossReferences":{"drugbank":["DB12508"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297316","canonicalSmiles":"CCC[C@@H](C)C[C@H](CN)CC(=O)O","inchiKey":"KKXFMWXZXDUYBF-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0299685","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD 0299685","Pd-0299685"],"crossReferences":{"drugbank":["DB15264"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297472","canonicalSmiles":"CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=S)[S-].[Na+]","inchiKey":"PLQRBFAACWRSKF-LJTMIZJLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NOX-100","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4301787","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NOX-100","Nox-100"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297483","canonicalSmiles":"CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1","inchiKey":"ZNKWRAKPQQZLNX-ZDQHWEPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVAFENTEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8871","AZD8871","Azd 8871","Azd-8871","Azd8871","LAS-191351","LAS191351","Navafenterol"],"childChemblIds":["CHEMBL4650222"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000133019"],"count":2},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297577","drugType":"Unknown","blackBoxWarning":false,"name":"BELAPECTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belapectin","GR-MD-02","Gr-md-02"],"linkedTargets":{"rows":["ENSG00000131981"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_0000756","EFO_0001421","EFO_1001249","EFO_0000676","EFO_0000666","EFO_0002617"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297771","drugType":"Unknown","blackBoxWarning":false,"name":"INTERLEUKIN-10","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human interleukin-10","Il-10","Interleukin-10"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297960","drugType":"Unknown","blackBoxWarning":false,"name":"DAVANAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Davanat","GM-CT-01","Galactomannan c","Gm-ct-01"],"linkedTargets":{"rows":["ENSG00000100097","ENSG00000131981"],"count":2},"linkedDiseases":{"rows":["EFO_0002617","EFO_1001951"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297994","drugType":"Unknown","blackBoxWarning":false,"name":"TILSOTOLIMOD SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMO-2125 sodium","TLR9 AGONIST IMO-2125","Tilsotolimod sodium"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0003047","EFO_0002617"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298086","drugType":"Antibody","blackBoxWarning":false,"name":"POZELIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pozelimab","REGN-3918","REGN3918","Regn3918"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["EFO_0004991","Orphanet_447"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL429844","canonicalSmiles":"CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O","inchiKey":"NTCCRGGIJNDEAB-IRXDYDNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORE-1001","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GL1001","Gl-1001","MLN-4760","ORE-1001 FREE ACID","ORE1001","Ore-1001","Ore1001"],"crossReferences":{"drugbank":["DB12271"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL43719","canonicalSmiles":"CCCCCCCNC=O","inchiKey":"YAUHDTOEJHVKJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTYLFORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Heptyl-Formamide"],"crossReferences":{"drugbank":["DB04105"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL439","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1","inchiKey":"SEEPANYCNGTZFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIAZINE","yearOfFirstApproval":1941,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adiazine","Coco-diazine","Diazyl","Sulfadiazine","Sulfapyrimidine","Sulfolex","Sulphadiazine"],"synonyms":["NSC-35600","SSD","Sildaflo","Silvadene","Sulfacombin","Sulfadiazine","Sulfadiazine (trisulfapyrimidines)","Sulphadiazine","Thermazene"],"crossReferences":{"DailyMed":["silver%20sulfadiazine","sulfadiazine"],"PubChem":["11112193","144203911","855872"],"Wikipedia":["Sulfadiazine"],"drugbank":["DB00359"],"chEBI":["9328"]},"childChemblIds":["CHEMBL1200351","CHEMBL1382627"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1941 and is indicated for bacterial disease and malaria and has 7 investigational indications."}
{"id":"CHEMBL447629","canonicalSmiles":"O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr","inchiKey":"VFKZTMPDYBFSTM-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOBRONITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myelobromol"],"synonyms":["DBM","Dibromomannitol","Mitobronitol","Myebrol","NSC-94100"],"crossReferences":{"PubChem":["144204630","144208362","29215109","46500622"],"Wikipedia":["Mitobronitol"],"drugbank":["DB13543"],"chEBI":["34853"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for neoplasm."}
{"id":"CHEMBL4594536","drugType":"Unknown","blackBoxWarning":false,"name":"CS-1003","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antibody cs1003","CS 1003","CS-1003","CS1003","Cs-1003","Cs1003","Nofazinlimab","Recombinant pd-1 mab cs1003"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL460287","canonicalSmiles":"C(COCCOCC1CO1)OCCOCC1CO1","inchiKey":"UMILHIMHKXVDGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOGLUCID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epodyl"],"synonyms":["Ethoglucid","Etoglucid","ICI 32865","ICI-32865","NSC-80439"],"crossReferences":{"drugbank":["DB13339"],"chEBI":["82542"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for neoplasm."}
{"id":"CHEMBL4650416","drugType":"Unknown","blackBoxWarning":false,"name":"PLASMALYTE A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plasma-lyte a","Plasmalyte a"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4650448","drugType":"Unknown","blackBoxWarning":false,"name":"S-55746","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCL-201","BCL201","Bcl201","S 055746","S-55746","S55746"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650462","drugType":"Antibody","blackBoxWarning":false,"name":"REGDANVIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-P59","Ct-p59","Regdanvimab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650504","drugType":"Unknown","blackBoxWarning":false,"name":"PEGYLATED CARBOXYHEMOGLOBIN (BOVINE)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PP-007","Pegylated carboxyhemoglobin (bovine)","Pp-007","Sanguinate"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650521","canonicalSmiles":"C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N","inchiKey":"UCJZOKGUEJUNIO-IINYFYTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNO-155","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ptpn11 inhibitor tno155","Shp2 inhibitor tno155","TNO-155","TNO155","Tno-155","Tno155"],"linkedTargets":{"rows":["ENSG00000179295"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL471144","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O","inchiKey":"GNZLUJQJDPRUTD-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5'-O-(Sulfamoyl)Adenosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-O-(Sulfamoyl)Adenosine","5'-O-Sulfamoyladenosine"],"crossReferences":{"drugbank":["DB02916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL474579","canonicalSmiles":"CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21","inchiKey":"SRZNHPXWXCNNDU-IXOPCIAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTETAN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefotan"],"synonyms":["Cefotetan","ICI 156,834","ICI-156834","Ici-156,834","NSC-760045"],"crossReferences":{"DailyMed":["cefotetan%20disodium"],"PubChem":["144204232","56463651"],"Wikipedia":["Cefotetan"],"drugbank":["DB01330"],"chEBI":["3499"]},"childChemblIds":["CHEMBL1201098"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for bacterial disease and infection and has 2 investigational indications."}
{"id":"CHEMBL50","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"REFJWTPEDVJJIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUERCETIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-hydroxykaempferol","C.I. Natural Red 1","C.i. 75670","Ci-75670","Corvitin","Cyanidenolon 1522","Korvitin","LDN 0052529","LDN-0052529","Lipoflavon","Meletin","NSC 57655","NSC 9219","NSC-57655","NSC-9219","Quercetin","Quercetine","Quercetol","Quertin","Quertine","Sophoretin","Xanthaurine"],"crossReferences":{"PubChem":["11111704","11111705","11111706","11113933","124881262","124881263","124881264","124881266","124881267","124881272","124881274","144209506","144210605","26747157","26752084","26752085","26752086","50104737","50104738","50104739","50113478","50113479","50113480","50113481","74741","85231204","90341524","99460891"],"Wikipedia":["Quercetin"],"drugbank":["DB04216"],"chEBI":["16243"]},"childChemblIds":["CHEMBL1520590","CHEMBL1173475"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL503565","canonicalSmiles":"CC/C=C(\\C)C1(CC)C(=O)NC(=O)NC1=O","inchiKey":"RAFOHKSPUDGZPR-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butenemal","NSC-117442","Vinbarbital","Vinbarbital sodium free acid","Vinbarbitone"],"crossReferences":{"Wikipedia":["Vinbarbital"],"drugbank":["DB13377"]},"childChemblIds":["CHEMBL2107295"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538943","canonicalSmiles":"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"CILBMBUYJCWATM-UDRBCWGGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINORELBINE TARTRATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL553025","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"crossReferences":{"PubChem":["144205824","170465330"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_1000172","EFO_0003869","EFO_0004708","EFO_0000571","MONDO_0007254","MONDO_0021063","EFO_0005952","MONDO_0001187","EFO_0000565","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0000183","EFO_1000158","EFO_0001416","EFO_0000616","MONDO_0001402","EFO_0000437","EFO_0000248","EFO_0000313","MONDO_0008315","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0006861","MONDO_0011962","EFO_0000233","EFO_0000574","MONDO_0017386","MONDO_0002863","MONDO_0002367","MONDO_0024880","EFO_0000691"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL591429","canonicalSmiles":"C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O","inchiKey":"YQNRVGJCPCNMKT-LFVJCYFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAC-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PAC-1","Pac-1","Procaspase-activating compound 1"],"crossReferences":{"PubChem":["50112924","90341778"],"drugbank":["DB13048"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL605003","canonicalSmiles":"CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2","inchiKey":"LOGJQOUIVKBFGH-YBEGLDIGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-6656","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-6656"],"crossReferences":{"PubChem":["11111835","50106863","50106864","56463485","85231238"],"Wikipedia":["SU6656"],"drugbank":["DB08039"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61733","canonicalSmiles":"Nc1nc(N)c2ncn(CCOCP(=O)(O)O)c2n1","inchiKey":"XHXFQGAZAVKMFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PMEDAP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL668","canonicalSmiles":"CNCCCC1c2ccccc2C=Cc2ccccc21","inchiKey":"BWPIARFWQZKAIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROTRIPTYLINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Protriptyline"],"crossReferences":{"DailyMed":["protriptyline%20hydrochloride"],"PubChem":["11111679","11111680","50100330","50104299","90341254"],"Wikipedia":["Protriptyline"],"drugbank":["DB00344"],"chEBI":["8597"]},"childChemblIds":["CHEMBL1200332"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0003761"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for unipolar depression and depressive disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL680","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1","inchiKey":"QYIYFLOTGYLRGG-GPCCPHFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFACLOR","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceclor","Raniclor"],"synonyms":["COMPOUND 99638","Cefaclor","Cefaclor hydrate"],"crossReferences":{"DailyMed":["cefaclor"],"PubChem":["144204431","170464885","29215008","855765"],"drugbank":["DB00833"],"chEBI":["3478"]},"childChemblIds":["CHEMBL1201018"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 9 approved and 1 investigational indication."}
{"id":"CHEMBL720","canonicalSmiles":"OCc1ccccc1","inchiKey":"WVDDGKGOMKODPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYL ALCOHOL","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ulesfia"],"synonyms":["Alcohol benzylicus","Alcohol,benzyl","Benzyl Alcohol","Benzyl alcohol","E-1519","E1519","FEMA NO. 2137","INS NO.1519","INS-1519","NSC-8044","Phenylcarbinol"],"crossReferences":{"PubChem":["124891475","144204723","144209645","144210364","17390015"],"Wikipedia":["Benzyl_alcohol"],"drugbank":["DB06770"],"chEBI":["17987"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 4 approved indications."}
{"id":"CHEMBL811","canonicalSmiles":"CN(C)CCC(c1ccc(Br)cc1)c1ccccn1","inchiKey":"ZDIGNSYAACHWNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMPHENIRAMINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BPN","Bromfed","Bromfenex","Brompheniramine","Brotane","Dimetane","Dimetapp","Lodrane"],"crossReferences":{"DailyMed":["brompheniramine%20maleate"],"PubChem":["90341200"],"Wikipedia":["Brompheniramine"],"drugbank":["DB00835"],"chEBI":["3183"]},"childChemblIds":["CHEMBL1200961"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0008521","HP_0012735","MONDO_0005271","EFO_0007214"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 3 approved indications."}
{"id":"CHEMBL859","canonicalSmiles":"O=c1[nH]c(=O)c2c[nH]nc2[nH]1","inchiKey":"HXNFUBHNUDHIGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPURINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-76239","Oxipurinol","Oxypurinol"],"crossReferences":{"PubChem":["144211537","57264357"],"Wikipedia":["Oxypurinol"],"drugbank":["DB05262"],"chEBI":["28315"]},"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL86304","canonicalSmiles":"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1","inchiKey":"YHXISWVBGDMDLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOCLOBEMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Manerix"],"synonyms":["Aurorix","GNF-PF-695","Moclobemide","RO 11-1163/000","RO-111163000"],"crossReferences":{"PubChem":["104171398","144204522","144207163","170465663","50086440","50105006","50105007","846440","90340853"],"Wikipedia":["Moclobemide"],"drugbank":["DB01171"],"chEBI":["83531"]},"linkedTargets":{"rows":["ENSG00000189221"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0003890","MONDO_0002050","HP_0000726","EFO_0003761","EFO_0003768","EFO_0005230"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and depressive disorder and has 5 investigational indications."}
{"id":"CHEMBL937","canonicalSmiles":"CCN(CC)C(=O)N1CCN(C)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"PGNKBEARDDELNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLCARBAMAZINE CITRATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL684","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banocide","Decacide","Difil","Dirocide","Filarabits","Hetrazan","Nemacide"],"synonyms":["Diethylcarbamazine Citrate","Diethylcarbamazine citrate","Ethylaminoazine citrate","Loxuran","NSC-80513"],"crossReferences":{"PubChem":["11112950","11532955","124882739","144204299","170465631","26747989","56422104"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950."}
